(NP (NP (NN Prostaglandin) (NN E2) (NN induction)) (PP (IN of) (NP (NP (NN binding) (NN activity)) (PP (TO to) (NP (NP-COOD (NP (NN CRE)) (CC and) (NP (NN AP-2))) (NNS elements))))) (PP (IN in) (NP (JJ human) (NN T) (NNS lymphocytes))) (. .))
(S (NP-SBJ (NP (NNP Prostaglandins)) (PP (IN of) (NP (DT the) (NN E) (NNS series)))) (VP (VBP are) (NP-PRD (NP (JJ immunomodulatory) (NNS agents)) (SBAR (WHNP-66 (WDT which)) (S (NP-SBJ (-NONE- *T*-66)) (VP (VBP exert) (NP (ADJP-COOD (ADJP (JJ inhibitory)) (CONJP (RB as) (RB well) (IN as)) (ADJP (JJ stimulatory))) (NNS effects)) (PP (IN on) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (JJ immune) (NNS responses)))))))))) (. .))
(S (SBAR (IN Since) (S (NP-SBJ (PRP it)) (VP (VBZ is) (VP (VBN known) (SBAR (IN that) (S (NP-SBJ-67 (NN PGE2)) (VP (VBZ is) (ADJP-PRD (JJ able) (S (NP-SBJ (-NONE- *-67)) (VP (TO to) (VP (VB increase) (NP (NN cAMP) (NNS levels))))))))))))) (, ,) (NP-SBJ (PRP we)) (VP (VBD investigated) (SBAR (IN whether) (S (NP-SBJ (PRP it)) (VP (MD can) (VP (VB affect) (NP (NN gene) (NN expression)) (PP (IN through) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NP (DT the) (NN transcription) (NNS factors)) (SBAR (WHNP-68 (WDT which)) (S (NP-SBJ (-NONE- *T*-68)) (VP (VBP bind) (NP (NP (NN enhancer) (NNS elements)) (PP (IN in) (NP (NP (DT the) (NN promoter) (NNS regions)) (PP (IN of) (NP (JJ cAMP-regulated) (NNS genes)))))))))))))))))) (. .))
(S (S (NP-SBJ (-NONE- *-69)) (VP (VBG Using) (NP (JJ electrophoretic) (NN mobility) (NN shift) (NN assay)))) (, ,) (NP-SBJ-69 (PRP we)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP-SBJ (NP (DT a) (JJ short) (NN treatment)) (PP (IN of) (NP (JJ human) (NN T) (NNS lymphocytes))) (PP (IN with) (NP (NN PGE2)))) (VP (VBZ induces) (NP (NP (JJ specific) (NN binding) (NN activity)) (PP (TO to) (NP (NP-COOD (NP (NN CRE)) (CC and) (NP-COOD (NP (NN AP-2)) (, ,) (NP (CC but) (RB not)) (NP (NN AP-1)) (, ,))) (NN DNA) (NNS elements)))))))) (. .))
(S (SBAR (IN Since) (S (NP-SBJ (NP (DT the) (JJ okadaic) (NN acid)) (, ,) (NP (DT a) (JJ potent) (NN protein) (NN phosphatase) (NN inhibitor)) (, ,)) (VP (VBZ prolongs) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (DT the) (NN binding) (NN activity))))))) (, ,) (NP-SBJ-70 (NN phosphorylation) (NNS events)) (VP (VBP are) (ADJP-PRD (JJ likely) (S (NP-SBJ (-NONE- *-70)) (VP (TO to) (VP (VB occur)))))) (. .))
(S (NP-SBJ-71 (DT This) (NN activity)) (VP (VBZ seems) (S (NP-SBJ (-NONE- *-71)) (VP (TO to) (VP (VB be) (PP-PRD (JJ due) (TO to) (NP (VBN increased) (NN cAMP) (NNS levels))) (SBAR (IN because) (S (NP-SBJ-COOD (NP (NN forskolin)) (CC and) (NP (NN IBMX))) (VP (VBP mimic) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NN PGE2))))))))))) (. .))
(S (ADVP (RBR More) (RB interestingly)) (, ,) (NP-SBJ (NP (NN transfection) (NNS experiments)) (PP (IN with) (NP (NN CRE-CAT) (NN plasmide)))) (VP (VBP show) (SBAR (IN that) (S (NP-SBJ (NN PGE2)) (VP (VBZ activates) (NP (NP (DT the) (NN transcription)) (PP (IN of) (NP (DT a) (NN CRE-containing) (NN promoter)))))))) (. .))
(S (NP-SBJ (DT These) (NNS data)) (VP (VBP support) (NP (NP (DT the) (JJ positive) (NN role)) (PP (IN for) (NP (NN PGE2))) (PP (IN on) (NP (DT some) (JJ immune) (NNS functions))))) (. .))
